The use of a reversible proteasome inhibitor in a model of Reduced-Size Orthotopic Liver transplantation in rats

Experimental and Molecular Pathology

Volumn 93, Issue 1, 2012, Pages 99-110

  Padrissa Altés, Susagna ^a   Zaouali, Mohamed Amine ^a   Boncompagni, Eleonora ^a   Bonaccorsi Riani, Eliano ^b   Carbonell, Teresa ^c   Bardag Gorce, Fawzia ^d   Oliva, Joan ^d   French, Samuel W ^d   Bartrons, Ramon ^c   Roselló Catafau, Joan ^a  

^a CSIC   (Spain)

^b INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^c UNIVERSITY OF BARCELONA   (Spain)

^d HARBOR UCLA MEDICAL CENTER   (United States)

Author keywords

Ischemia reperfusion injury; Liver regeneration; Reduced Size Orthotopic Liver transplantation; Ubiquitin proteasome system

Indexed keywords

BORTEZOMIB; HEAT SHOCK PROTEIN 70; HEME OXYGENASE 1; NITRIC OXIDE SYNTHASE; PRESERVATIVE; PROTEASOME INHIBITOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENDOPLASMIC RETICULUM STRESS; LIVER GRAFT; LIVER INJURY; LIVER ISCHEMIA; LIVER MITOCHONDRION; LIVER REGENERATION; LIVER TRANSPLANTATION; MALE; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; RAT; REDUCED SIZE ORTHOTOPIC LIVER TRANSPLANTATION; REPERFUSION INJURY; TISSUE PRESERVATION;

ANIMALS; BORONIC ACIDS; ENDOPLASMIC RETICULUM STRESS; ENZYME INHIBITORS; HEME OXYGENASE (DECYCLIZING); HSP70 HEAT-SHOCK PROTEINS; LIVER REGENERATION; LIVER TRANSPLANTATION; MALE; MITOCHONDRIA, LIVER; NITRIC OXIDE SYNTHASE TYPE III; ORGAN SIZE; OXIDATIVE STRESS; PROTEASOME ENDOPEPTIDASE COMPLEX; PYRAZINES; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY;

RATTUS;

EID: 84860821570     PISSN: 00144800     EISSN: 10960945     Source Type: Journal    
DOI: 10.1016/j.yexmp.2012.03.011     Document Type: Article

References (74)

1. Akerman P., Cote P., Yang S.Q., McClain C., Nelson S., Bagby G.J., Diehl A.M. Antibodies to tumor necrosis factor-alpha inhibit liver regeneration after partial hepatectomy. American Journal of Physiology 1992, 263:G579-G585.
2. Alexandrova A., Petrov L., Georgieva A., Kessiova M., Tzvetanova E., Kirkova M., Kukan M. Effect of MG132 on proteasome activity and prooxidant/antioxidant status of rat liver subjected to ischemia/reperfusion injury. Hepatology Research 2008, 38:393-401.
3. Alfany-Fernandez I., Casillas-Ramirez A., Bintanel-Morcillo M., Brosnihan K.B., Ferrario C.M., Serafin A., Rimola A., Rodes J., Rosello-Catafau J., Peralta C. Therapeutic targets in liver transplantation: angiotensin II in nonsteatotic grafts and angiotensin-(1-7) in steatotic grafts. American Journal of Transplantation 2009, 9:439-451.
4. Anan A., Baskin-Bey E.S., Isomoto H., Mott J.L., Bronk S.F., Albrecht J.H., Gores G.J. Proteasome inhibition attenuates hepatic injury in the bile duct-ligated mouse. American Journal of Physiology. Gastrointestinal and Liver Physiology 2006, 291:G709-G716.
5. Badet L., Ben Abdennebi H., Petruzzo P., McGregor B., Espa M., Hadj-Aissa A., Ramella-Virieux S., Steghens J.P., Portoghese F., Martin X. Effect of IGL-1, a new preservation solution, on kidney grafts (a pre-clinical study). Transplant International 2005, 17:815-821.
6. Badet L., Petruzzo P., Lefrancois N., McGregor B., Espa M., Berthillot C., Danjou F., Contu P., Aissa A.H., Virieux S.R., Colpart J.J., Martin X. Kidney preservation with IGL-1 solution: a preliminary report. Transplantation Proceedings 2005, 37:308-311.
7. Bardag-Gorce F., Oliva J., Lin A., Li J., French B.A., French S.W. Proteasome inhibitor up regulates liver antioxidative enzymes in rat model of alcoholic liver disease. Experimental and Molecular Pathology 2011, 90:123-130.
8. Bedford L., Lowe J., Dick L.R., Mayer R.J., Brownell J.E. Ubiquitin-like protein conjugation and the ubiquitin-proteasome system as drug targets. Nature Reviews. Drug Discovery 2011, 10:29-46.
9. Ben Abdennebi H., Elrassi Z., Scoazec J.Y., Steghens J.P., Ramella-Virieux S., Boillot O. Evaluation of IGL-1 preservation solution using an orthotopic liver transplantation model. World Journal of Gastroenterology 2006, 12:5326-5330.
10. Ben Mosbah I., Rosello-Catafau J., Franco-Gou R., Abdennebi H.B., Saidane D., Ramella-Virieux S., Boillot O., Peralta C. Preservation of steatotic livers in IGL-1 solution. Liver Transplantation 2006, 12:1215-1223.
11. Ben Mosbah I., Rosello-Catafau J., Alfany-Fernandez I., Rimola A., Parellada P.P., Mitjavila M.T., Lojek A., Ben Abdennebi H., Boillot O., Rodes J., Peralta C. Addition of carvedilol to University Wisconsin solution improves rat steatotic and nonsteatotic liver preservation. Liver Transplantation 2010, 16:163-171.
12. Blais J.D., Filipenko V., Bi M., Harding H.P., Ron D., Koumenis C., Wouters B.G., Bell J.C. Activating transcription factor 4 is translationally regulated by hypoxic stress. Molecular and Cellular Biology 2004, 24:7469-7482.
13. Busuttil R.W., Tanaka K. The utility of marginal donors in liver transplantation. Liver Transplantation 2003, 9:651-663.
14. Campbell B., Adams J., Shin Y.K., Lefer A.M. Cardioprotective effects of a novel proteasome inhibitor following ischemia and reperfusion in the isolated perfused rat heart. Journal of Molecular and Cellular Cardiology 1999, 31:467-476.
15. Ciechanover A. The ubiquitin-proteasome proteolytic pathway. Cell 1994, 79:13-21.
16. Cullinan S.B., Diehl J.A. PERK-dependent activation of Nrf2 contributes to redox homeostasis and cell survival following endoplasmic reticulum stress. Journal of Biological Chemistry 2004, 279:20108-20117.
17. Cullinan S.B., Zhang D., Hannink M., Arvisais E., Kaufman R.J., Diehl J.A. Nrf2 is a direct PERK substrate and effector of PERK-dependent cell survival. Molecular and Cellular Biology 2003, 23:7198-7209.
18. Ding W.X., Ni H.M., Gao W., Yoshimori T., Stolz D.B., Ron D., Yin X.M. Linking of autophagy to ubiquitin-proteasome system is important for the regulation of endoplasmic reticulum stress and cell viability. American Journal of Pathology 2007, 171:513-524.
19. Elliott P.J., Ross J.S. The proteasome: a new target for novel drug therapies. American Journal of Clinical Pathology 2001, 116:637-646.
20. Fenteany G., Schreiber S.L. Lactacystin, proteasome function, and cell fate. Journal of Biological Chemistry 1998, 273:8545-8548.
21. Fernandez L., Carrasco-Chaumel E., Serafin A., Xaus C., Grande L., Rimola A., Rosello-Catafau J., Peralta C. Is ischemic preconditioning a useful strategy in steatotic liver transplantation?. American Journal of Transplantation 2004, 4:888-899.
22. Foschi D., Castoldi L., Lesma A., Musazzi M., Benevento A., Trabucchi E. Effects of ischaemia and reperfusion on liver regeneration in rats. European Journal of Surgery 1993, 159:393-398.
23. Franco-Gou R., Peralta C., Massip-Salcedo M., Xaus C., Serafin A., Rosello-Catafau J. Protection of reduced-size liver for transplantation. American Journal of Transplantation 2004, 4:1408-1420.
24. Franco-Gou R., Rosello-Catafau J., Casillas-Ramirez A., Massip-Salcedo M., Rimola A., Calvo N., Bartrons R., Peralta C. How ischaemic preconditioning protects small liver grafts. The Journal of Pathology 2006, 208:62-73.
25. Franco-Gou R., Mosbah I.B., Serafin A., Abdennebi H.B., Rosello-Catafau J., Peralta C. New preservation strategies for preventing liver grafts against cold ischemia reperfusion injury. Journal of Gastroenterology and Hepatology 2007, 22:1120-1126.
26. Gallucci R.M., Simeonova P.P., Toriumi W., Luster M.I. TNF-alpha regulates transforming growth factor-alpha expression in regenerating murine liver and isolated hepatocytes. Journal of Immunology 2000, 164:872-878.
27. Ge P., Luo Y., Liu C.L., Hu B. Protein aggregation and proteasome dysfunction after brain ischemia. Stroke 2007, 38:3230-3236.
28. Geng Q., Romero J., Saini V., Baker T.A., Picken M.M., Gamelli R.L., Majetschak M. A subset of 26S proteasomes is activated at critically low ATP concentrations and contributes to myocardial injury during cold ischemia. Biochemical and Biophysical Research Communications 2009, 390:1136-1141.
29. Harding H.P., Zhang Y., Zeng H., Novoa I., Lu P.D., Calfon M., Sadri N., Yun C., Popko B., Paules R., Stojdl D.F., Bell J.C., Hettmann T., Leiden J.M., Ron D. An integrated stress response regulates amino acid metabolism and resistance to oxidative stress. Molecular Cell 2003, 11:619-633.
30. Jing H., Shen G., Wang G., Zhang F., Li Y., Luo F., Yao J., Tian X.F. MG132 alleviates liver injury induced by intestinal ischemia/reperfusion in rats: involvement of the AhR and NFkappaB pathways. The Journal of Surgical Research 2011, 1-11.
31. Kahn D., Robson S.C., Hickman R. The effect of a tumour necrosis factor antibody on the regenerative response after partial hepatectomy in rats. Transplant International 1994, 7(Suppl. 1):S181-S182.
32. Kane R.C., Dagher R., Farrell A., Ko C.W., Sridhara R., Justice R., Pazdur R. Bortezomib for the treatment of mantle cell lymphoma. Clinical Cancer Research 2007, 13:5291-5294.
33. Kawasaki S., Makuuchi M., Matsunami H., Hashikura Y., Ikegami T., Nakazawa Y., Chisuwa H., Terada M., Miyagawa S. Living related liver transplantation in adults. Annals of Surgery 1998, 227:269-274.
34. Kim R., Emi M., Tanabe K., Murakami S. Role of the unfolded protein response in cell death. Apoptosis 2006, 11:5-13.
35. Lassot I., Segeral E., Berlioz-Torrent C., Durand H., Groussin L., Hai T., Benarous R., Margottin-Goguet F. ATF4 degradation relies on a phosphorylation-dependent interaction with the SCF(betaTrCP) ubiquitin ligase. Molecular and Cellular Biology 2001, 21:2192-2202.
36. Lassot I., Estrabaud E., Emiliani S., Benkirane M., Benarous R., Margottin-Goguet F. p300 modulates ATF4 stability and transcriptional activity independently of its acetyltransferase domain. Journal of Biological Chemistry 2005, 280:41537-41545.
37. Lee D.H., Goldberg A.L. Proteasome inhibitors: valuable new tools for cell biologists. Trends in Cell Biology 1998, 8:397-403.
38. Majetschak M., Patel M.B., Sorell L.T., Liotta C., Li S., Pham S.M. Cardiac proteasome dysfunction during cold ischemic storage and reperfusion in a murine heart transplantation model. Biochemical and Biophysical Research Communications 2008, 365:882-888.
39. Malago M., Rogiers X., Broelsch C.E. Reduced-size hepatic allografts. Annual Review of Medicine 1995, 46:507-512.
40. Massip-Salcedo M., Casillas-Ramirez A., Franco-Gou R., Bartrons R., Ben Mosbah I., Serafin A., Rosello-Catafau J., Peralta C. Heat shock proteins and mitogen-activated protein kinases in steatotic livers undergoing ischemia-reperfusion: some answers. American Journal of Pathology 2006, 168:1474-1485.
41. Massip-Salcedo M., Zaouali M.A., Padrissa-Altes S., Casillas-Ramirez A., Rodes J., Rosello-Catafau J., Peralta C. Activation of peroxisome proliferator-activated receptor-alpha inhibits the injurious effects of adiponectin in rat steatotic liver undergoing ischemia-reperfusion. Hepatology 2008, 47:461-472.
42. Meng L., Mohan R., Kwok B.H., Elofsson M., Sin N., Crews C.M. Epoxomicin, a potent and selective proteasome inhibitor, exhibits in vivo antiinflammatory activity. Proceedings of the National Academy of Sciences of the United States of America 1999, 96:10403-10408.
43. Murray R.Z., Norbury C. Proteasome inhibitors as anti-cancer agents. Anti-Cancer Drugs 2000, 11:407-417.
44. Myung J., Kim K.B., Crews C.M. The ubiquitin-proteasome pathway and proteasome inhibitors. Medicinal Research Reviews 2001, 21:245-273.
45. Ogata M., Hino S., Saito A., Morikawa K., Kondo S., Kanemoto S., Murakami T., Taniguchi M., Tanii I., Yoshinaga K., Shiosaka S., Hammarback J.A., Urano F., Imaizumi K. Autophagy is activated for cell survival after endoplasmic reticulum stress. Molecular and Cellular Biology 2006, 26:9220-9231.
46. Oyadomari S., Mori M. Roles of CHOP/GADD153 in endoplasmic reticulum stress. Cell Death and Differentiation 2004, 11:381-389.
47. Oyadomari S., Takeda K., Takiguchi M., Gotoh T., Matsumoto M., Wada I., Akira S., Araki E., Mori M. Nitric oxide-induced apoptosis in pancreatic beta cells is mediated by the endoplasmic reticulum stress pathway. Proceedings of the National Academy of Sciences of the United States of America 2001, 98:10845-10850.
48. Oyadomari S., Araki E., Mori M. Endoplasmic reticulum stress-mediated apoptosis in pancreatic beta-cells. Apoptosis 2002, 7:335-345.
49. Oyadomari S., Koizumi A., Takeda K., Gotoh T., Akira S., Araki E., Mori M. Targeted disruption of the Chop gene delays endoplasmic reticulum stress-mediated diabetes. The Journal of Clinical Investigation 2002, 109:525-532.
50. Padrissa-Altes S., Franco-Gou R., Boillot O., Serafin A., Rimola A., Arroyo V., Rodes J., Peralta C., Rosello-Catafau J. Effect of angiotensin II and bradykinin inhibition in rat reduced-size liver transplantation. Liver Transplantation 2009, 15:313-320.
51. Padrissa-Altes S., Zaouali M.A., Franco-Gou R., Bartrons R., Boillot O., Rimola A., Arroyo V., Rodes J., Peralta C., Rosello-Catafau J. Matrix metalloproteinase 2 in reduced-size liver transplantation: beyond the matrix. American Journal of Transplantation 2010, 10:1167-1177.
52. Peralta C., Hotter G., Closa D., Gelpi E., Bulbena O., Rosello-Catafau J. Protective effect of preconditioning on the injury associated to hepatic ischemia-reperfusion in the rat: role of nitric oxide and adenosine. Hepatology 1997, 25:934-937.
53. Pickart C.M. Mechanisms underlying ubiquitination. Annual Review of Biochemistry 2001, 70:503-533.
54. Portugal V., Garcia-Alonso I., Barcelo P., Mendez J. Effect of allopurinol, folinic acid, SOD and cyclosporine A on ischemic liver regeneration. European Surgical Research 1995, 27:69-76.
55. Powell S.R., Wang P., Katzeff H., Shringarpure R., Teoh C., Khaliulin I., Das D.K., Davies K.J., Schwalb H. Oxidized and ubiquitinated proteins may predict recovery of postischemic cardiac function: essential role of the proteasome. Antioxidants & Redox Signaling 2005, 7:538-546.
56. Rudic B., Song H., Breedijk A., Brinkkoetter P., Beck G., Yard B., Ponelies N. Hypothermic preservation up-regulates calpain expression and increases ubiquitination in cultured vascular endothelial cells: influence of dopamine pretreatment. The Journal of Surgical Research 2010, 160:325-332.
57. Rzymski T., Milani M., Singleton D.C., Harris A.L. Role of ATF4 in regulation of autophagy and resistance to drugs and hypoxia. Cell Cycle 2009, 8:3838-3847.
58. Samstein B., Emond J. Liver transplants from living related donors. Annual Review of Medicine 2001, 52:147-160.
59. Schiano T.D., Kim-Schluger L., Gondolesi G., Miller C.M. Adult living donor liver transplantation: the hepatologist's perspective. Hepatology 2001, 33:3-9.
60. Schroder M., Kaufman R.J. ER stress and the unfolded protein response. Mutation Research 2005, 569:29-63.
61. Selzner M., Camargo C.A., Clavien P.A. Ischemia impairs liver regeneration after major tissue loss in rodents: protective effects of interleukin-6. Hepatology 1999, 30:469-475.
62. Shintani T., Klionsky D.J. Autophagy in health and disease: a double-edged sword. Science 2004, 306:990-995.
63. Suh K.S., Goy A. Bortezomib in mantle cell lymphoma. Future Oncology 2008, 4:149-168.
64. Vembar S.S., Brodsky J.L. One step at a time: endoplasmic reticulum-associated degradation. Nature Reviews Molecular Cell Biology 2008, 9:944-957.
65. Wei A.H., Roberts A.W. Bortezomib: putting mantle cell lymphoma on death row. Leukemia & Lymphoma 2008, 49:657-658.
66. Yamada Y., Kirillova I., Peschon J.J., Fausto N. Initiation of liver growth by tumor necrosis factor: deficient liver regeneration in mice lacking type I tumor necrosis factor receptor. Proceedings of the National Academy of Sciences of the United States of America 1997, 94:1441-1446.
67. Yao J.H., Li Y.H., Wang Z.Z., Zhang X.S., Wang Y.Z., Yuan J.C., Zhou Q., Liu K.X., Tian X.F. Proteasome inhibitor lactacystin ablates liver injury induced by intestinal ischaemia-reperfusion. Clinical and Experimental Pharmacology and Physiology 2007, 34:1102-1108.
68. Yorimitsu T., Klionsky D.J. Endoplasmic reticulum stress: a new pathway to induce autophagy. Autophagy 2007, 3:160-162.
69. Zaouali M.A. Insulin-like Growth Factor-1 increases fatty liver preservation in IGL-1 solution. World Journal of Gastroenterology 2010, 16:5693-5700.
70. Zaouali M.A., Ben Mosbah I., Boncompagni E., Ben Abdennebi H., Mitjavila M.T., Bartrons R., Freitas I., Rimola A., Rosello-Catafau J. Hypoxia inducible factor-1alpha accumulation in steatotic liver preservation: role of nitric oxide. World Journal of Gastroenterology 2010, 16:3499-3509.
71. Zaouali M.A., Mosbah I.B., Abdennebi H.B., Calvo M., Boncompagni E., Boillot O., Peralta C., Rosello-Catafau J. New insights into fatty liver preservation using Institute Georges Lopez preservation solution. Transplantation Proceedings 2010, 42:159-161.
72. Zaouali M.A., Padrissa-Altes S., Ben Mosbah I., Ben Abdennebi H., Boillot O., Rimola A., Saidane-Mosbahi D., Rosello-Catafau J. Insulin like growth factor-1 increases fatty liver preservation in IGL-1 solution. World Journal of Gastroenterology 2010, 16:5693-5700.
73. Zaouali M.A., Reiter R.J., Padrissa-Altes S., Boncompagni E., Garcia J.J., Ben Abnennebi H., Freitas I., Garcia-Gil F.A., Rosello-Catafau J. Melatonin protects steatotic and nonsteatotic liver grafts against cold ischemia and reperfusion injury. Journal of Pineal Research 2011, 50:213-221.
74. Zinszner H., Kuroda M., Wang X., Batchvarova N., Lightfoot R.T., Remotti H., Stevens J.L., Ron D. CHOP is implicated in programmed cell death in response to impaired function of the endoplasmic reticulum. Genes & Development 1998, 12:982-995.